Himsnab Bulgaria AD

BUL:CHSB Rapport sur les actions

Capitalisation boursière : лв163.4m

Himsnab Bulgaria AD Résultats passés

Passé contrôle des critères 5/6

Himsnab Bulgaria AD has been growing earnings at an average annual rate of 13.4%, while the Real Estate industry saw earnings declining at 29.9% annually. Revenues have been growing at an average rate of 33.7% per year. Himsnab Bulgaria AD's return on equity is 6.1%, and it has net margins of 14.4%.

Informations clés

13.4%

Taux de croissance des bénéfices

13.4%

Taux de croissance du BPA

Real Estate Croissance de l'industrie-4.1%
Taux de croissance des recettes33.7%
Rendement des fonds propres6.1%
Marge nette14.4%
Dernière mise à jour des bénéfices31 Dec 2023

Mises à jour récentes des performances passées

Recent updates

Himsnab Bulgaria AD's (BUL:CHSB) Business Is Yet to Catch Up With Its Share Price

Apr 07
Himsnab Bulgaria AD's (BUL:CHSB) Business Is Yet to Catch Up With Its Share Price

We're Not Counting On Himsnab Bulgaria AD (BUL:58E) To Sustain Its Statutory Profitability

Feb 12
We're Not Counting On Himsnab Bulgaria AD (BUL:58E) To Sustain Its Statutory Profitability

Could Mixed Fundamentals Be The Reason For Himsnab Bulgaria AD's (BUL:58E) Unexciting Performance On The Stock Market?

Jan 17
Could Mixed Fundamentals Be The Reason For Himsnab Bulgaria AD's (BUL:58E) Unexciting Performance On The Stock Market?

If You Had Bought Himsnab Bulgaria AD (BUL:58E) Shares Five Years Ago You'd Have Earned 39% Returns

Dec 16
If You Had Bought Himsnab Bulgaria AD (BUL:58E) Shares Five Years Ago You'd Have Earned 39% Returns

Himsnab Bulgaria AD (BUL:58E) Has A Pretty Healthy Balance Sheet

Nov 24
Himsnab Bulgaria AD (BUL:58E) Has A Pretty Healthy Balance Sheet

Ventilation des recettes et des dépenses

Comment Himsnab Bulgaria AD gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.


Historique des gains et des recettes

BUL:CHSB Recettes, dépenses et bénéfices (BGN Millions )
DateRecettesLes revenusDépenses G+ADépenses de R&D
31 Dec 2362960
30 Sep 23104650
30 Jun 2398750
31 Mar 2391650
31 Dec 2239550
30 Sep 22571170
30 Jun 2234540
31 Mar 2232440
31 Dec 2131440
30 Sep 219210
30 Jun 2129440
31 Mar 2127440
31 Dec 2025440
30 Sep 2026450
30 Jun 2027450
31 Mar 2028450
31 Dec 1927450
30 Sep 1922440
30 Jun 1920530
31 Mar 1919530
31 Dec 1819430
30 Sep 1821-1130
30 Jun 1822-830
31 Mar 1820-730
31 Dec 1721130
30 Sep 17191340
30 Jun 17201240
31 Mar 17211340
31 Dec 1619540
30 Sep 1616230
30 Jun 1612030
31 Mar 167520
31 Dec 157530
30 Sep 1561020
30 Jun 1561020
31 Mar 156220
31 Dec 146120
30 Sep 146520
30 Jun 145520
31 Mar 144420
31 Dec 133410

Des revenus de qualité: CHSB has high quality earnings.

Augmentation de la marge bénéficiaire: CHSB's current net profit margins (14.4%) are higher than last year (12.2%).


Analyse des flux de trésorerie disponibles par rapport aux bénéfices


Analyse de la croissance passée des bénéfices

Tendance des revenus: CHSB's earnings have grown by 13.4% per year over the past 5 years.

Accélération de la croissance: CHSB's earnings growth over the past year (86.5%) exceeds its 5-year average (13.4% per year).

Bénéfices par rapport au secteur d'activité: CHSB earnings growth over the past year (86.5%) exceeded the Real Estate industry 3.5%.


Rendement des fonds propres

ROE élevé: CHSB's Return on Equity (6.1%) is considered low.


Rendement des actifs


Rendement des capitaux employés


Découvrir des entreprises performantes dans le passé